Skip to main content

December 2016

 

 

academics

 

Clinical research courses

Amgen announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for an extension to the marketing authorization of a new 420 mg single-dose delivery option for Repatha (evolocumab). The new automated mini doser (AMD) with prefilled cartridge is a hands-free device designed to provide 420 mg of Repatha in a single injection per administration. Repatha is a human monoclonal antibody that blocks a protein called proprotein convertase subtilisin/kexin type 9 (PCSK9), which inhibits the body's natural system for eliminating "bad" cholesterol (low-density lipoprotein cholesterol or LDL-C) from the blood.

Amgen and UCB announced that an application seeking marketing approval of romosozumab for the treatment of osteoporosis for those at high risk of fracture has been submitted for review to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. Amgen and UCB are co-developing romosozumab worldwide, with development in Japan being led by Amgen Astellas BioPharma (AABP) K.K., a joint venture between Amgen and Astellas Pharma Inc., a pharmaceutical company headquartered in Tokyo.

Amedica Corporation, a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced encouraging results from a recent study showing rapid bone growth into porous silicon nitride. Explants of the company's porous silicon nitride from a large-animal model demonstrated bone healing into the material just four weeks after implantation. "We anticipate these preliminary findings will be confirmed with additional retrieval data in the near future.

AMTZ (Andhra MedTech Zone) aims to make India a self-sufficient and in fact an exporter of good quality and cost-effective medical technology.

The objective of the Seminar was to familiarize the Industry on this opportunity which exists in fulfilling this gap which is likely to only widen as the healthcare services reach out to semi-urban and rural areas. The seminar also threw up opportunities for foreign collaborations for technology transfers and financing for setting up units.

Job for Pharmacist( 08 posts) at Government Hospital

Applications are invited from eligible candidates for the post of Pharmacist in the prescribed format given below for selection and engagement on contractual basis under the administrative control of CDMO. The application for the above posts should reach in the office of the CDMO Kandhamal, Phulbani, Pin - 762001 through Speed Post & Regd. Post only on or before 09.01.2017 by 5 PM. The applications received after the due date shall not be considered under any circumstances.

Post : Pharmacist Group - C   

Vacancies for Pharmacists (5 posts) in Office of the CDMO | Government Job

Applications in the prescribed proforma are invited from eligible candidates for selection and engagement of the following paramedical posts under the Chief District Medical Officer, Jajpur to be filled on Contractual basis with monthly remuneration mentioned against each of the post. The application for the above posts should reach in the office of the Chief District Medical Officer, At / Po / Dist. Jajpur PIN.755001, through Speed Post / Regd. Post only on or before Dt.09.01.2017 by 05.00 P.M. The application received after due date shall not be considered under any circumstances and will be rejected. The candidate has to apply separate application for separate post.

Post : Pharmacist

Job for B.Pharm, M.Pharm in Internal control and compliance at VARITE

VARITE has recently ranked #124 in the Entrepreneur Magazines HOT 500 list of fastest growing businesses in America. With operations in USA, CANADA and INDIA, VARITE is currently engaged with leading technology, networking, telecommunication, companies to provide software consulting, team augmentation and key business process outsourcing services.

Post : Internal control and compliance

Career Opportunities in Pharmacovigilance QA as Senior Manager at Novartis

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Senior Manager, Pharmacovigilance QA

Opening to work as Brand Management - BRM in P&G

Procter & Gamble is the innovation leader in our industry. Virtually all the organic sales growth we’ve delivered in the past nine years has come from new brands and new or improved product innovation. We continually strengthen our innovation capability and pipeline by investing two times more, on average, than our major competitors. P&G. We interact with more than five million consumers each year in nearly 60 countries around the world. We conduct over 15,000 research studies every year. We invest more than $350 million a year in consumer understanding. This results in insights that tell us where the innovation opportunities are and how to serve and communicate with consumers.

Post: Brand Management - BRM

Career for Biostatistician at GlaxoSmithKline

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 5000+ people. Globally, we are a £ 27.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer. This mission drives us to make a real difference to the lives of millions of people with our commitment to effective healthcare solutions.

Post : Biostatistician